chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a 5 year old female who, "at one year of age", in approximately 2002, was vaccinated with a dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wister RA 27/3). "At that time", in approximately 2002, the patient developed a fever, rash and malaise. It was reported that the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Follow-up information from a physician indicated that the patient was not under the reporter's care at that time, the patient was fine, and that there was no additional information available. Additional information is not expected.
Pain in neck on same side as vaccine; Very swollen armpit on same side; Very swollen armpit on same side. Painful as well; Administration date 13Oct2021 at 09:30, dose number=3; This is a spontaneous report from a contactable other healthcare professional, the patient. A 52-year-old non-pregnant female patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 13Oct2021 at 09:30 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history and no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included the first dose of influenza vaccine (MANUFACTURER UNKNOWN) in the left arm on 04Oct2021, estradiol (ESTRACE) and progesterone (MANUFACTURER UNKNOWN); all from an unknown date for unknown indication and unknown if ongoing. The patient previously received the the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL1284) via an unspecified route of administration in the left arm on 06Jan2021 at 13:00 (at the age of 51-years-old) and the patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3246) via an unspecified route of administration in the left arm on 27Jan2021 at 13:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. On 13Oct2021 at 09:30, the patient had "administration date 13Oct2021 at 09:30, dose number=3". On 13Oct2021 at 20:30, the patient had pain in neck on same side as vaccine and very swollen armpit on same side, painful as well. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events pain in neck on same side as vaccine, very swollen armpit on same side and painful as well was not resolved at the time of this report. The clinical outcome of the event "administration date 13Oct2021 at 09:30, dose number=3" was unknown at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
WHOLE BODY MUSCLE ACHES; HEADACHE; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020 expiry: UNKNOWN) dose was not reported, administered on 20-MAR-2021 for prophylactic vaccination on left deltoid. No concomitant medications were reported. On 21-MAR-2021, the subject experienced whole body muscle aches. On 21-MAR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from whole body muscle aches, and headache. This report was non-serious.
she and her parents got a 0.5ml dose on 02sep21 and then they know that the booster was 0.25ml; sweating, wrenched in sweat; difficult to move; difficult to walk; sore arm; low grade fever; chills, could not get warm, bone chills; headache, hit like a ton of bricks; every joint hurt; body aches; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating, wrenched in sweat), MOBILITY DECREASED (difficult to move), GAIT DISTURBANCE (difficult to walk), PAIN IN EXTREMITY (sore arm) and PYREXIA (low grade fever) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 052E21A, 031M20A and 001B21) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Lumpectomy (Breast lumpectomy (microcalcification)). Concurrent medical conditions included Smoker and Kikuchi disease. Concomitant products included ETHINYLESTRADIOL, NORGESTIMATE (ESTARYLLA) for Birth control, CELECOXIB (CELEBREX) for Rheumatoid arthritis, MONTELUKAST SODIUM (SINGULAIR) for an unknown indication.   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Sep-2021, the patient experienced ACCIDENTAL OVERDOSE (she and her parents got a 0.5ml dose on 02sep21 and then they know that the booster was 0.25ml). In September 2021, the patient experienced HYPERHIDROSIS (sweating, wrenched in sweat), MOBILITY DECREASED (difficult to move), GAIT DISTURBANCE (difficult to walk), PAIN IN EXTREMITY (sore arm), PYREXIA (low grade fever), CHILLS (chills, could not get warm, bone chills), HEADACHE (headache, hit like a ton of bricks), ARTHRALGIA (every joint hurt) and MYALGIA (body aches). On 02-Sep-2021, ACCIDENTAL OVERDOSE (she and her parents got a 0.5ml dose on 02sep21 and then they know that the booster was 0.25ml) had resolved. In September 2021, HYPERHIDROSIS (sweating, wrenched in sweat), MOBILITY DECREASED (difficult to move), GAIT DISTURBANCE (difficult to walk), PAIN IN EXTREMITY (sore arm), PYREXIA (low grade fever), CHILLS (chills, could not get warm, bone chills), HEADACHE (headache, hit like a ton of bricks), ARTHRALGIA (every joint hurt) and MYALGIA (body aches) had resolved.            Concomitant medication claritin daily 10mg was reported. It was reported that the first day was horrible, it peaked, the second day was not so much, the third had started getting better. PATIENT went down for 48hs in bed.   This case was linked to MOD-2021-377778 (Patient Link).
Patient has had a rash, redness, low grade fever, nausea, and soreness for 7+ days
pt rcvd vax & had erythema, edema, hot, induration with puritis in the area in the left muscle where the vaccine was administered;
got the Flu.; Initial information received  on 26-Nov-2022 regarding an unsolicited valid non-serious case from a consumer/non-health care professional.  This case involves an unknown age and unknown gender patient who  got the flu after receiving vaccine Influenza Vaccine.  The patient's past medical history, medical treatment(s), vaccination(s), concomitant(s) and family history were not provided.   On an unknown date, the patient vaccinated with a dose of suspect influenza vaccine produced by unknown manufacturer (strength, formulation, frequency, dosage, lot number, and expiry date: not reported) via unknown route in unknown administration site for prophylactic vaccination and got the flu (influenza) (unknown latency).  No lab data was reported.  Action taken was not applicable.  It was not reported if the patient received a corrective treatment for the event.   The outcome was Unknown.
Case previously recorded as MA2009-5172. Initial case report received from a physician via MedCom on 19 NOV 2009. A 63 week-old male patient was vaccinated with S-OIV FLUVIRIN (batch no. 102124P1) i.m. on 13 NOV 2009. No adverse events were reported. MedCom reference no.: NA09-008308.
pt lives in Unknown, Quality Center for Rehab and Healing; 3/3/22 pt had a positive COVID test in the center; O2 via NC; pt found unresponsive on 3/12/22, pt expired
Sore arm; This is a spontaneous report from a contactable consumer (patient). A 28-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL9261), via an unspecified route of administration in arm left on 23Jan2021 15:45 (age at vaccination was 28 Years) as dose 1, single for covid-19 immunisation at school or student health clinic. Medical history included bipolar disorder and bell's palsy (twice). Known allergies were unknown. Concomitant medication(s) received in two weeks included lamotrigine (LAMICTAL), vitamin D NOS, biotin, amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) and birth control; all were taken for an unspecified indication, start and stop date were not reported. No other vaccine was received in four weeks prior to the COVID vaccine. On an unspecified date, the patient experienced sore arm. No covid prior vaccination and no covid tested post vaccination. Outcome of the event was unknown.    Follow-up attempts completed. No further information expected.
This spontaneous report was received from a 77-year-old female patient reporting on herself with drug hypersensitivity to Codeine and no pertinent medial history reported. However, it was mentioned that the patient was taken concomitant therapies, but the patient refused to disclose them. On an unspecified date in 2008, the patient was vaccinated with a dose of ZOSTAVAX, dose and frequency reported as "1 vaccine" (dose number, route, anatomical location, lot number and expiration date were not reported), for prophylaxis reported as to prevent the shingles. In August 2015, the patient experienced a serious case of shingles (Herpes Zoster). Later, on an unspecified date (also reported as "after the shingles"), she had some permanent nerve damage (Nerve injury) which covered her midriff and her back. Additionally, the patient reported that she underwent laboratory tests (unspecified) twice a year (results not provided). On an unspecified date, the patient sought medical attention (information was not provided), and as a result, she was prescribed with different medications (unspecified). The patient reported that for 10 days she took some antiviral (unspecified) and then pain pills (unspecified) but she only took the pain pills once or twice since that medication did not make her feel good. At the time of this report, it was unknown if the patient recovered or not from the adverse events and she currently took "gabentin". The causal relationship between the adverse events and the therapy with ZOSTAVAX was not provided. No product quality complaint was involved. The reporter considered serious case of shingles (Herpes Zoster) to be medically significant. Additional information is not expected as the reporter did not wish further contact.
Information has been received from a licensed practical nurse referring to a patient of unknown age and gender. On 12-JUL-2016 a dose of improperly stored M-M-R II (lot# L027591 rHA, expiration date 23-JUL-2017) was given to the patient. No adverse effects reported. The temperature excursion was 48 degree Fahrenheit for 24 hours, data logger was used. There was no prior excursion. The temperature was back in range at the time of reporting. This is one of several reports received from the same source. Additional information is not expected as there is no consent to contact the physician.
This spontaneous report was received from a physician via a company representative refers to a patient of unknown age and gender. No medical history was reported. On an unknown date, the patient was vaccinated with a standard dose of 0.5 ml of GARDASIL, (lot#, route  not reported). No concomitant medications were reported. On an unknown date, the patient experienced developing syncope months after receiving GARDASIL. The outcome of syncope was unknown. The relatedness for syncope with GARDASIL was unknown. Additional information is not expected.
Patient received her dose around 5:10pm.  She did not report any anaphylaxis or allergies prior to vaccination.  She was monitored for 15 minutes and then left the facility.  She had driven about 5-7 miles and then started to feel as if her throat was tightening/closing in.  She stated that she could not swallow her saliva.  She stated that her tongue felt tingly.   She turned around in the car and returned to the facility.  She arrived around1745.  She was able to talk freely, although she stated that her voice was lower than normal.  She did not exhibit any facial or neck swelling and did not have any rash to her trunk or to her injection site.  She denied itching.  Initial vital signs: BP 124/74, p-79, SaO2 99%.  She stated that she was sensitive to Diphenhydramine and could not take that medication.  During the next 5-10 minutes, her symptoms did not progress.  She then revealed her history of CRPS/reflex sympathetic dystrophy.  She stated that she had sensitivities to many medications, and that she just doesn't know until she tries one.  She denies ever having anaphylaxis but states that she thinks she has come close to it a few times, but "rides it out".  She also stated a history of asthma, and that how she was feeling was similar to how she feels after an asthma attack.  Asked her if she had a rescue inhaler with her, but she stated that she did not.  She was further observed, and at 1810 the left side of her throat was improving but the right side was still tight.  Five minutes later, she stated that she was then able to swallow.  By 1820, she stated that everything was improved.  She felt well enough to return home.  Another set of VS were taken:  BP 110/60, P-68, SaO2 99%.  She was instructed to let her husband drive her home and to follow up with her PCP regarding this episode and follow-up.  She was additionally instructed that if her symptoms worsened, that she was to call 911.  Also talked to her husband and instructed him regarding worsening of symptoms and follow-up.  Called client today 4/23/21 at 11:30 and she reports that she did have a similar episode of the sensation like her throat was closing yesterday 4/22/21, but it resolved on its own without intervention.  She also reported nausea and lightheadedness s/p vaccination.  She states that she is feeling fine today.
Client received a lower dose of Covid 19 then recommended for her age. She had no adverse reactions.
48 hours post injection large swelling with cutaneous blisters. Treated for cellulitis.
Received tetanus booster 5/27/2021 L deltoid.   Left humeral pain at injection site and when received the tetanus shot experienced transient nerve pain in L wrist that has not occurred since.   Pain with lifting and also movements of L arm/shoulder.   No redness or focal swelling at the injection site, no pruritis.   No fever or chills.
fever of 101.7 degrees, chills, aches, fatigue, nausea. have been happening since last night and have continued into today
ADMINISTRATION OF SECOND DOSE OF VACCINE; OFF LABEL USE; This spontaneous report received from a health care professional concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported. On an unspecified date, the subject experienced administration of second dose of vaccine, and off label use. The action taken with covid-19 vaccine  was not applicable. The outcome of the administration of second dose of vaccine and off label use was not reported. This report was non-serious.
Initial unsolicited report received from a consumer via other company (Pfizer) (Manufacturer Report Number: 2016454043) on 11 October 2016. This case involves a 10-months-old female patient who was vaccinated with an injection of DPT (batch number, expiry date, dose, dose in series, route and site of administration and manufacturer were not reported) in an unknown site on 27 October 1994 (reported as possibly on 27 October 1994). The patient's medical history and concomitant medications were not reported. On an unknown date, unspecified time following the vaccination, the patient experienced lethargy and crying. The patient's laboratory data and corrective treatment was not reported. The patient's outcome was not reported. List of documents held by sender: none.
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 66-year-old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications.  On an unknown date in 2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route were not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced shingles. On an unspecified date, the patient was treated by a physician for shingles. The outcome of the event was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).
Injection given by RN at DHMC into acromiun capsule  right arm. Site became  very red , edematous and very hot to touch.  2 days later, still edematous, warm and patchy.
@15:42 patient received her 4th dose ( pfizer bivalent booster) on her left arm intramuscularly , @ 15:54 patient had a witnessed syncopal episode by rn ,  rn assisted the client , no injury noted , patient regained consciousness immediately , md , emt , safety officer were called , patient is aox4 , no shortness of breath , cold clammy skin upon touch with diaphoresis , blood sugar was taken @0404 bs of 96mg/dl , temp of 96.2f , hr of 68 and bp of  110/68 , snacks and 1 bottle of water  given , @0420 patient verbalized that she feels better , dr asked emt to do another set of vital signs , bp of 110/60 , hr of 63 , temp of 96.8 and blood sugar of 85mg/dl , 1 bottle of energy drink was given and patient finished drinking it . patient has no complaints at this time , denies sob and dizziness , aox4 , patient was discharge on a stable condition by dr @ 04:35 .
acute adhesive capsulitis of the R shoulder Narrative: Employee seeing shoulder surgeon, starting physical therapy soon, recs are for at least 1 year.
Symptoms:  Swelling of the tongue, fever blisters on tongue, swelling of the lips and glands on the side of the face, rash and hives on arms, tightening & swelling of the throat.  Took two Benadryl 25mg. after consulting Dr. and after four hours with symptoms.  Three hours later symptoms got worse so I went into urgent care. They gave me a shot of dexamethasone (2mg), and oral prednisone 20mg, 2 pills per day for 5days.   After three hours symptoms got significantly better.
Initial unsolicited report received from a consumer via other company (Pfizer) on 25-Nov-2015. Manufacturer control number: 2015406514. This case involves a 94-year-old female patient, who was vaccinated with a dose of INFLUENZA VACCINE (Flu shot) (Batch number: unknown) and PREVNAR13 (manufacturer: Pfizer, batch number: unknown) (dose, dose in series, route of administration were not reported for both vaccines) both in left arm on 21-Oct-2015 in the morning at 11:00 A.M. Patient had no illness at the time of vaccination and had medical history of chronic bronchitis, thyroid disorder and blood pressure. Patient had received Levoxyl (once a day) for thyroid, unspecified drug (once a day) for stomach and unspecified drug (low dose once a day) for blood pressure as concomitant medications. On 21-Oct-2015, few hours after vaccination, the patient experienced sickness, weakness, she could could hardly sleep and her arm was sore. On an unspecified date patient experienced difficulty in walking (when sitting could hardly get up and go). It was reported that patient had received flu shots, pneumonia shots and the shingles shot before and never had any bad reactions in the past. No laboratory investigations were performed and corrective treatment was not reported. On an unspecified date, patient recovered from the event of arm sore (duration: few days). At the time of this report patient had not recovered from events of sickness, weakness and difficulty in walking (when sitting can hardly get up and go) and the outcome of the event could hardly sleep was unknown. Documents held by sender: none.
Left upper arm swelling, redness, painful arm, warm to the touch. Patient described "goose flesh" rash.
NO ADVERSE REACTIONS.  PATIENT GIVEN EXPIRED VACCINATION (EXP DATE 9-21-21)
CHILD RECEIVED 2 VACCINES OF MCV4. LAST ONE RECEIVED WAS 01/27/2017. NO ISSUES AT THIS TIME.
Case number PHEH2011US05683 is an initial spontaneous report received from a nurse on 30 Sep 2011: This case refers to a 52-years-old male patient. His medical history included headache, decreased appetite, low grade fever, a tender gland, and swelling in the right area of the gland. These symptoms were started about one week before FLUVIRIN vaccination. He was vaccinated with FLUVIRIN (batch number: 1100601) intramuscularly on 27 Sep 2011. Blood test was reported to be "positive for Influenza A and B". A rapid flu test was performed after vaccination with FLUVIRIN and it was found weakly positive and then went to negative. No exact dates were provided for blood test and rapid flu test. The causality and event outcome were not reported.
DEVELOPED URITICIA OVER HER FACE, EYE, TRUNK AND EXTREMITIES 36 HOURS AFTER RECEIVED HER IMMUNIZATIONS. SHE WAS TREATED WITH ORAL BENADRYL X 2. URTICARIA SUB-SIDED. NO OTHER SYMPTOMS/
Had a slight sore arm that did not even last 1 day; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Had a slight sore arm that did not even last 1 day) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced PAIN IN EXTREMITY (Had a slight sore arm that did not even last 1 day). In March 2021, PAIN IN EXTREMITY (Had a slight sore arm that did not even last 1 day) had resolved.            Patient had a slight sore arm that did not even last 1 day after both the first and second dose.  No concomitant medication were reported. No treatment information was provided by the reporter.   This case was linked to MOD-2021-433404, MOD-2021-433638 (Patient Link).
This spontaneous report was received from a nurse refers to an unspecified number of patients of unknown age and gender. No concurrent condition or medical history was reported. On an unknown date the patient was vaccinated with improperly stored (29.6 F for 26 hours) RECOMBIVAX HB (lot # K012874, Exp. 19-JUN-2016, dose and route of administration was not provided). No concomitant therapy was reported. There was no previous temperature excursion. No adverse symptoms were reported. The outcome of the event was unknown. No product quality issue was involved. This is one of the several reports from the same reporter link. Additional information has been requested.
Patient limped on her leg and experienced severe pain at the injection site lasting a few days. There was a very hard, large lump at the injection site that was painful to the touch and lasted several months.